跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 202 条关于
“mPDAC”
全部
202
临床试验
174
药物
4
机构
2
资讯
22
去年
NALIRIFOX Shows Numerically Improved Overall Survival Compared to FOLFIRINOX in Metastatic PDAC
2年前
Oleclumab Plus Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
去年
Phase 1 Trial Shows Promise for PSCA-Targeted BPX-601 CAR T-Cell Therapy in Pancreatic and Prostate Cancers
去年
Elraglusib Receives EMA Orphan Drug Designation for Pancreatic Cancer Treatment
去年
Lisata's Certepetide Shows Promising Results in Phase 2b Pancreatic Cancer Trial
去年
Elraglusib Plus Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
去年
Oncolytics Biotech Appoints $2B Deal Architect as CEO to Advance Pelareorep Immunotherapy
去年
Ivaltinostat Shows Promise in Phase 1b Trial for Metastatic Pancreatic Cancer
9个月前
Phanes Therapeutics to Present First Clinical Data for Spevatamig in Metastatic Pancreatic Cancer at ASCO GI 2026
2年前
Certepetide Shows Promise in Metastatic Pancreatic Cancer: Lisata Therapeutics Announces Encouraging Phase 2 Results
第 1 页,共 3 页
上一页
下一页